Angiosarcomas of the head and neck: a clinico-immunohistochemical study of 8 consecutive patients

International Journal of Oral and Maxillofacial Surgery

Volumn 39, Issue 6, 2010, Pages 568-572

  Yang, X J ^a   Zheng, J W ^a   Zhou, Q ^a   Ye, W M ^a   Wang, Y A ^a   Zhu, H G ^a   Wang, L Z ^a   Zhang, Z Y ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

angiosarcoma; CD31; CD34; immunohistochemistry; malignant hemangioendothelioma

Indexed keywords

ANTINEOPLASTIC AGENT; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN; CYTOKERATIN; TUMOR MARKER; TUMOR ANTIGEN;

ADULT; AGED; ANGIOSARCOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISTANT METASTASIS; FACE; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INOPERABLE CANCER; MALE; PARANASAL SINUS; PHARYNX; PROGNOSIS; SCALP; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; ADJUVANT THERAPY; CASE REPORT; CHEMISTRY; FATALITY; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; ANTIGENS, CD34; ANTIGENS, NEOPLASM; FACTOR VIII; FATAL OUTCOME; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TUMOR MARKERS, BIOLOGICAL;

EID: 77953286030     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2010.03.004     Document Type: Article

References (32)

1. Abraham J.A., Hornicek F.J., Kaufman A.M., Harmon D.C., Springfield D.S., Raskin K.A., Mankin H.J., Kirsch D.G., Rosenberg A.E., Nielsen G.P., Desphpande V., Suit H.D., DeLaney T.F., and Yoon S.S. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 14 (2007) 1953-1967
2. Aust M.R., Olsen K.D., Lewis J.E., Nascimento A.G., Meland N.B., Foote R.L., and Suman V.J. Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otol Rhinol Laryngol 106 (1997) 943-951
3. Buschmann A., Lehnhardt M., Toman N., Preiler P., Salakdeh M.S., and Muehlberger T. Surgical treatment of angiosarcoma of the scalp: less is more. Ann Plast Surg 61 (2008) 399-403
4. Cha C., Antonescu C.R., Quan M.L., Maru S., and Brennan M.F. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg 239 (2004) 903-910
5. De Young B.R., Swanson P.E., Argenyi Z.B., Ritter J.H., Fitzgibbon J.F., Stahl D.J., Hoover W., and Wick M.R. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. J Cutan Pathol 22 (1995) 215-222
6. De Young B.R., Frierson Jr. H.F., Ly M.N., Smith D., and Swanson P.E. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 110 (1998) 374-377
7. Driemel O., Müller-Richter U.D., Hakim S.G., Bauer R., Berndt A., Kleinheinz J., Reichert T.E., and Kosmehl H. Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma. Head Face Med 4 (2008) 17
8. Fury M.G., Antonescu C.R., Van Zee K.J., Brennan M.F., and Maki R.G. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 11 (2005) 241-247
9. Hodgkinson D.J., Soule E.H., and Woods J.E. Cutaneous angiosarcoma of the head and neck. Cancer 44 (1979) 1106-1113
10. Holden C.A., Spittle M.F., and Jones E.W. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 59 (1987) 1046-1057
11. Hunt S.J., and Santa Cruz D.J. Vascular tumors of the skin: a selective review. Semin Diagn Pathol 21 (2004) 166-218
12. Isogai R., Kawada A., Aragane Y., and Tezuka T. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel. J Dermatol 31 (2004) 335-341
13. Koch M., Nielsen G.P., and Yoon S.S. Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol 97 (2008) 321-329
14. Köhler H.F., Neves R.I., Brechtbühl E.R., Mattos Granja N.V., Ikeda M.K., and Kowalski L.P. Cutaneous angiosarcoma of the head and neck: report of 23 cases from a single institution. Otolaryngol Head Neck Surg 139 (2008) 519-524
15. Leowardi C., Hinz U., Hormann Y., Wente M.N., Mechtersheimer G., Willeke F., Böckler D., Friess H., Allenberg J.R., Herfarth C., Büchler M.W., and Schwarzbach M.H. Malignant vascular tumors: clinical presentation, surgical therapy, and long-term prognosis. Ann Surg Oncol 12 (2005) 1090-1101
16. Lydiatt W.M., Shaha A.R., and Shah J.P. Angiosarcoma of the head and neck. Am J Surg 168 (1994) 451-454
17. Mark R.J., Poen J.C., Tran L.M., Fu Y.S., and Juillard G.F. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 77 (1996) 2400-2406
18. Meis-Kindblom J.M., and Kindblom L.G. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 22 (1998) 683-697
19. Mendenhall W.M., Mendenhall C.M., Werning J.W., Reith J.D., and Mendenhall N.P. Cutaneous angiosarcoma. Am J Clin Oncol 29 (2006) 524-528
20. Mertens F., Unni K., and Fletcher C.D.M. Pathology and Genetics. Tumors of Soft Tissue and Bone (2002), IARC Press, Lyon, World Health Organization 175-177
21. Miettinen M., Lindenmayer A.E., and Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7 (1994) 82-90
22. Morgan M.B., Swann M., Somach S., Eng W., and Smoller B. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol 50 (2004) 864-867
23. Morrison W.H., Byers R.M., Garden A.S., Evans H.L., Ang K.K., and Peters L.J. Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer 76 (1995) 319-327
24. Muñoz M., Monje F., Alonso del Hoyo J.R., and Martín-Granizo R. Oral angiosarcoma misdiagnosed as a pyogenic granuloma. J Oral Maxillofac Surg 56 (1998) 488-491
25. Nappi O., Wick M.R., Pettinato G., Ghiselli R.W., and Swanson P.E. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. Am J Surg Pathol 16 (1992) 429-438
26. Ohsawa M., Naka N., Tomita Y., Kawamori D., Kanno H., and Aozasa K. Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Cancer 75 (1995) 2867-2874
27. Pawlik T.M., Paulino A.F., McGinn C.J., Baker L.H., Cohen D.S., Morris J.S., Rees R., and Sondak V.K. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 98 (2003) 1716-1726
28. Requena L., and Sangueza O.P. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms. J Am Acad Dermatol 38 (1998) 143-175
29. Rossi S., and Fletcher C.D. Angiosarcoma arising in hemangioma/vascular malformation: report of four cases and review of the literature. Am J Surg Pathol 26 (2002) 1319-1329
30. Sarasin A., Weedon D., Burg G., and LeBoit P.E. Pathology and Genetics of Skin Tumors (2006), IARC Press, Lyon, World Health Organization 20-25, 245-246
31. Skubitz K.M., and Haddad P.A. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 104 (2005) 361-366
32. Vogt T., Hafner C., Bross K., Bataille F., Jauch K.W., Berand A., Landthaler M., Andreesen R., and Reichle A. Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer (2003) 2251-2256